LMP2A (426-434) is a HLA-A2-restricted cytotoxic T lymphocyte (CTL) epitope of Epstein-Barr virus (EBV) latent membrane protein 2A (LMP2A). LMP2A (426-434) can trigger an immune response in individuals expressing different HLA-A*02 subtypes (A*02:01, A*02:03, A*02:06 and A*02:07). LMP2A (426-434) can induce a strong IFN-gamma secretion response, stimulating the production of a high proportion of CD8+ IFN-gamma+ T cells. LMP2A (426-434) induces specific CTLs to effectively kill target cells expressing LMP2A. LMP2A (426-434) can be used to study EBV-related malignant tumors (such as Hodgkins disease and nasopharyngeal carcinoma) [1][2].
Molekulargewicht:
906.16
Reinheit:
96.09
CAS Nummer:
[152274-91-4]
Formel:
C39H71N9O11S2
Target-Kategorie:
EBV,IFNAR
Anwendungsbeschreibung:
MCE Product type: Peptides
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten